TARA - ArTara Therapeutics Inc Stock Price, Fair Value and News

$2.31-0.01 (-0.43%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

TARA Price Action

Last 7 days

-14.1%

Last 30 days

14.9%

Last 90 days

8.5%

Trailing 12 Months

102.6%

TARA RSI Chart

TARA Valuation

Market Cap

47.7M

Price/Earnings (Trailing)

-1.13

Price/Sales (Trailing)

203.15

Price/Free Cashflow

-1.51

TARA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TARA Fundamentals

TARA Revenue

Revenue (TTM)

262.0K

TARA Earnings

Earnings (TTM)

-42.0M

Earnings Growth (Yr)

-13.78%

Earnings Growth (Qtr)

-17.93%

TARA Profitability

Return on Equity

-51.41%

Return on Assets

-44.69%

Free Cashflow Yield

-66.22%

TARA Investor Care

Shares Dilution (1Y)

81.52%

Diluted EPS (TTM)

-2.82

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2019	449.0K	416.0K	356.0K	262.0K
2018	319.0K	379.0K	409.0K	436.0K
2017	169.0K	162.0K	199.0K	259.0K
2016	160.0K	176.0K	188.0K	193.0K
2015	2.2M	1.5M	845.0K	144.0K
2014	0	0	0	2.9M

Get all data in R, Python etc through our Historical Stock Data APIs

About ArTara Therapeutics Inc

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. The company is headquartered in New York, New York.

CEO	Mr. Jesse Shefferman
WEBSITE	protaratx.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	25

ArTara Therapeutics Inc Frequently Asked Questions

What is the ticker symbol for ArTara Therapeutics Inc? What does TARA stand for in stocks?

TARA is the stock ticker symbol of ArTara Therapeutics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ArTara Therapeutics Inc (TARA)?

As of Wed Nov 20 2024, market cap of ArTara Therapeutics Inc is 47.65 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TARA stock?

You can check TARA's fair value in chart for subscribers.

Is ArTara Therapeutics Inc a good stock to buy?

The fair value guage provides a quick view whether TARA is over valued or under valued. Whether ArTara Therapeutics Inc is cheap or expensive depends on the assumptions which impact ArTara Therapeutics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TARA.

What is ArTara Therapeutics Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Nov 20 2024, TARA's PE ratio (Price to Earnings) is -1.13 and Price to Sales (PS) ratio is 203.15. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TARA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on ArTara Therapeutics Inc's stock?

In the past 10 years, ArTara Therapeutics Inc has provided -0.405 (multiply by 100 for percentage) rate of return.